NDC product

Regadenoson

NDC 0407-5034 · GE Healthcare Inc.

Key facts

Product NDC 0407-5034
Proprietary name Regadenoson
Labeler GE Healthcare Inc.
Marketing category ANDA
Application number ANDA215955
Marketing start Mar 28, 2025
Marketing end Feb 16, 2026
Listing certified through Feb 16, 2026

At a glance

  • 1–9 Package NDCs

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About National Drug Codes (NDC)

The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.

Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date:

Browse all National Drug Codes (NDC)